Guggenheim Capital LLC Bio Techne Corp Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 12,261 shares of TECH stock, worth $895,420. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,261
Previous 12,833 4.46%
Holding current value
$895,420
Previous $919,000 6.53%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$70.96 - $82.35 $40,589 - $47,104
-572 Reduced 4.46%
12,261 $979,000
Q2 2024

Aug 14, 2024
SELL
$62.12 - $84.15 $187,726 - $254,301
-3,022 Reduced 19.06%
12,833 $919,000
Q1 2024

May 14, 2024
BUY
$65.98 - $77.09 $15,241 - $17,807
231 Added 1.48%
15,855 $1.12 Million
Q4 2023

Feb 14, 2024
SELL
$52.83 - $78.22 $8,241 - $12,202
-156 Reduced 0.99%
15,624 $1.21 Million
Q3 2023

Nov 14, 2023
SELL
$67.52 - $89.42 $16,812 - $22,265
-249 Reduced 1.55%
15,780 $1.07 Million
Q2 2023

Aug 11, 2023
SELL
$73.76 - $85.98 $208,814 - $243,409
-2,831 Reduced 15.01%
16,029 $1.31 Million
Q1 2023

May 10, 2023
SELL
$71.62 - $86.62 $2.25 Million - $2.72 Million
-31,349 Reduced 62.44%
18,860 $1.4 Million
Q4 2022

Feb 14, 2023
BUY
$80.67 - $352.29 $2.78 Million - $12.2 Million
34,501 Added 219.64%
50,209 $4.16 Million
Q3 2022

Nov 14, 2022
SELL
$282.54 - $391.85 $555,191 - $769,985
-1,965 Reduced 11.12%
15,708 $4.46 Million
Q2 2022

Aug 15, 2022
SELL
$322.67 - $449.65 $337,835 - $470,783
-1,047 Reduced 5.59%
17,673 $6.13 Million
Q1 2022

May 16, 2022
SELL
$353.85 - $487.79 $755,469 - $1.04 Million
-2,135 Reduced 10.24%
18,720 $8.11 Million
Q4 2021

Feb 14, 2022
BUY
$456.15 - $525.06 $2.41 Million - $2.77 Million
5,273 Added 33.84%
20,855 $10.8 Million
Q3 2021

Nov 15, 2021
SELL
$444.87 - $538.88 $115,221 - $139,569
-259 Reduced 1.63%
15,582 $7.55 Million
Q2 2021

Aug 13, 2021
SELL
$387.35 - $450.26 $159,975 - $185,957
-413 Reduced 2.54%
15,841 $7.13 Million
Q1 2021

May 13, 2021
SELL
$314.62 - $411.0 $342,935 - $447,990
-1,090 Reduced 6.28%
16,254 $6.21 Million
Q4 2020

Feb 16, 2021
SELL
$246.9 - $321.87 $885,877 - $1.15 Million
-3,588 Reduced 17.14%
17,344 $5.51 Million
Q3 2020

Nov 13, 2020
SELL
$232.22 - $282.96 $659,040 - $803,040
-2,838 Reduced 11.94%
20,932 $5.19 Million
Q2 2020

Aug 14, 2020
BUY
$185.43 - $279.56 $461,164 - $695,265
2,487 Added 11.69%
23,770 $6.28 Million
Q1 2020

Jun 02, 2020
SELL
$161.17 - $221.51 $618,892 - $850,598
-3,840 Reduced 15.28%
21,283 $4.04 Million
Q4 2019

Feb 14, 2020
BUY
$189.68 - $222.09 $1.04 Million - $1.22 Million
5,494 Added 27.99%
25,123 $5.52 Million
Q3 2019

Nov 14, 2019
SELL
$183.56 - $216.72 $2.16 Million - $2.55 Million
-11,773 Reduced 37.49%
19,629 $3.84 Million
Q2 2019

Aug 14, 2019
BUY
$188.72 - $215.43 $1.26 Million - $1.43 Million
6,655 Added 26.89%
31,402 $6.55 Million
Q1 2019

May 15, 2019
SELL
$136.09 - $200.44 $151,059 - $222,488
-1,110 Reduced 4.29%
24,747 $4.91 Million
Q4 2018

Feb 14, 2019
SELL
$132.75 - $203.8 $784,552 - $1.2 Million
-5,910 Reduced 18.6%
25,857 $3.74 Million
Q3 2018

Nov 14, 2018
SELL
$147.44 - $204.11 $659,646 - $913,188
-4,474 Reduced 12.35%
31,767 $6.48 Million
Q2 2018

Aug 14, 2018
SELL
$144.9 - $165.58 $5.52 Million - $6.31 Million
-38,099 Reduced 51.25%
36,241 $5.36 Million
Q1 2018

May 15, 2018
SELL
$131.46 - $151.04 $515,454 - $592,227
-3,921 Reduced 5.01%
74,340 $11.2 Million
Q4 2017

Feb 14, 2018
SELL
$121.17 - $134.75 $3.17 Million - $3.53 Million
-26,171 Reduced 25.06%
78,261 $10.1 Million
Q3 2017

Nov 14, 2017
BUY
$113.59 - $123.78 $11.9 Million - $12.9 Million
104,432
104,432 $12.6 Million

Others Institutions Holding TECH

# of Institutions
602
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email